KNTE

Kinnate Biopharma Inc. Common Stock
KNTE

Overview Fund Activity
Delisted

KNTE was delisted on the 2nd of April, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Kinnate Biopharma Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 56 closing their positions.

Holders
–
Holders Change
-56
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
56
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
FCMI
1
Foresite Capital Management IV
California
$0
2
O
2
OrbiMed
New York
$0
3
FCMV
3
Foresite Capital Management V
California
$0
4
LCM
4
Lynx1 Capital Management
Puerto Rico
$0
5
Viking Global Investors
5
Viking Global Investors
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CFM
51
Catalyst Funds Management
Australia
– -$4.18K -1,570 Closed
TRCT
52
Tower Research Capital (TRC)
New York
– -$2.9K -1,091 Closed
UBS Group
53
UBS Group
Switzerland
– -$2.18K -818 Closed
CL
54
CSS LLC
Illinois
– -$1.55K -584 Closed
Wells Fargo
55
Wells Fargo
California
– -$383 -144 Closed
1 2
3